IDF Europe is a consortium member of the EU Innovative Medicines Initiative research project, Trials@Home, which aims to reshape clinical trial design, conduct and operations, by developing and piloting standards, recommendations and tools for the definition and operationalization of decentralized clinical trials (DCTs) in Europe.
Within the project, IDF Europe has established a Patient Expert Panel (PEP) to facilitate the engagement of people living with diabetes (PwD) and to ensure that their experiences, needs and preferences are heard. The PEP has, for example, contributed to the development of an inclusive informed consent process and of a communication and messaging framework; has reviewed training materials for people in the trial; and has participated in various outreach activities.
Mia Bajramagic, type 1 diabetes (T1D) advocate and IDF Europe Project Coordinator answered some questions about the role of IDF Europe and the PEP in the project.
 |
